Tyers Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$10.7M Buy
210,540
+65,428
+45% +$3.07M 0.35% 59
2019
Q2
$6.58M Buy
145,112
+109,164
+304% +$5.08M 0.22% 91
2019
Q1
$1.72M Buy
35,948
+14,872
+71% +$741K 0.06% 241
2018
Q4
$1.09M Sell
21,076
-2,948
-12% -$158K 0.04% 269
2018
Q3
$1.49M Sell
24,024
-374
-2% -$22.2K 0.05% 244
2018
Q2
$1.35M Sell
24,398
-4,686
-16% -$253K 0.05% 258
2018
Q1
$1.84M Buy
29,084
+4,686
+19% +$301K 0.06% 217
2017
Q4
$1.5M Buy
24,398
+11,374
+87% +$711K 0.05% 231
2017
Q3
$830K Buy
+13,024
New +$760K 0.03% 301
2017
Q1
Sell
-13,992
Closed -$818K 975
2016
Q4
$818K Buy
+13,992
New +$765K 0.03% 282

Other funds holding BMY

Tyers Asset Management's BMY Position: Q3 2019 in Review

Tyers Asset Management increased its Bristol-Myers Squibb (BMY) stake by 45% in Q3 2019, buying an estimated $3.07M and bringing the position to 210,540 shares worth $10.7M. The position accounts for 0.35% of the portfolio, ranked #59.

Tyers Asset Management first reported a position in BMY in Q4 2016 and has held it in 10 quarters since. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

  • Tyers Asset Management held 210,540 shares of Bristol-Myers Squibb worth $10.7M as of Q3 2019.
  • Tyers Asset Management bought 65,428 Bristol-Myers Squibb shares in Q3 2019, an estimated $3.07M.
  • Bristol-Myers Squibb made up 0.35% of Tyers Asset Management's portfolio in Q3 2019, its #59 holding.
  • Tyers Asset Management first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 10 quarters since.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.